Platelet Lymphocyte Ratio is Associated With Carotid Atherosclerosis in Hemodialysis Patients
Abstract
Objective: We aimed to demonstrate whether there is a correlation between Platelet Lymphocyte Ratio (PLR) and carotid intima-media thickness (CIMT) which is an early marker of atherosclerosis in patients receiving dialysis where there is a chronic inflammatory process in the body.
Methods: 53 patients receiving dialysis 3 days a week and 54 persons as the control group were included. The exclusion criteria were determined as infection, using drugs that increase or decrease the number of leukocytes such as steroids, antithyroid, chronic liver diseases, rheumatic disease, maling disease and prior cardiovascular or cerebrovascular diseases. Patients’ age, gender, body mass index, hemogram and biochemical parameters were recorded. CIMT values were measured by Carotid Doppler examination.
Results: When the two groups were compared; there was no significant difference between them in terms of age, gender, blood pressures, DM, ejection fractions, lipid levels. PLR, neutrophil-to-lymphocyte ratio (NLR) and CIMT were significantly higher (p=0.009, p<0.001, p<0.001; respectively) in the dialysis patients group. A positive correlation was found between CIMT and PLR, NLR (r=0.59 p<0.001, r=0.38, p=0.004). As a result of the linear regression analysis, PLR (B:0.714, 95%CI:3.425/14.393, p=0.002) and NLR were found as independent predictors in showing CIMT.
Conclusion: PLR is independently associated with subclinical atherosclerosis assessed by CIMT in people with dialysis patients
Keywords
platelet-to-lymphocyte ratio,carotid intima media thickness,chronic renal failure
References
- Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94.
- Fukuda H, Takagi T, Kondo T, Shimizu S, Tanabe K. et al. Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy. Oncotarget. 2018;9(18):14296-14305.
- Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H. et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013;8:e67688.
- Ikeda U. Inflammation and coronary artery disease. Curr Vasc Pharmacol 2003; 1:65–70
- Jiang Y, Qu S, Xinbin Pan X, Huang S, Zhu X. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma. Oncotarget. 2018; 9(11): 9992–10004
- Kalay N, Dogdu O, Koc F, Yarlioglues M, Ardic I, Akpek M. et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63:213–7.
- Ozcan Cetin EH, Cetin MS, Aras D, Topaloglu S, Temizhan A, Kisacik HL.et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology 2016;67:336-45
- Tola EN. The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples. Taiwan J Obstet Gynecol. 2018;57(2):289-294
- Trakarnwijitr I, Li B, Adams H, Layland J, Garlick J, Wilson A. Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease. Int J Cardiol. 2017;248:349-354. doi: 10.1016/j.ijcard.2017.06.127.
- Wei Y, Jiang YZ, Qian WH. Prognostic role of NLR in urinary cancers: a meta-analysis. PLoS One. 2014;9(3):e92079.